Recursion Pharmaceuticals, LLC

Salt Lake City, UT 84108

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.12MM
First Award Date 03/01/15
Most Recent Award Date 09/15/16

Key Personnel

Last Name Name Awards Contact
GIBSON CHRISTOPHER GIBSON 4
STRAESSLER KRYSTAL MARIE STRAESSLER 1
DONATO ANTHONY JOHN DONATO 1

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/15/16 - 08/31/17

? DESCRIPTION (provided by applicant): Chronic diseases of aging account for a significant proportion of healthcare spending and result in a painful and limiting existence for many tens of millions of Americans and hundreds of millions of people around the world. Recursion Pharmaceuticals has developed a drug discovery platform that re-purpo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 03/01/16 - 02/28/17

DESCRIPTION (provided by applicant): There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis and transcellular resi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/18/15 - 03/31/16

DESCRIPTION (provided by applicant): Cornelia de Lange Syndrome is a complex congenital malformations syndrome with many post-natal progressive medical complications. CdLS has a clear genetic cause with loss of function mutations in NIPBL accounting for over 65% of the genetically confirmed CdLS cases. The remaining cases exhibit mutations in su...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 08/15/15 - 01/31/16

DESCRIPTION (provided by applicant): There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis using machine-learnin...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 03/01/15 - 02/29/16

DESCRIPTION (provided by applicant): There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis and transcellular resi...